AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PUMA VCT 13 PLC

Regulatory Filings May 3, 2022

5003_rns_2022-05-03_ea570c5c-cd18-4a7c-bea6-63fb8770fe84.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0874K

Puma VCT 13 PLC

03 May 2022

Puma VCT 13 plc (the "Company")

3 May 2022

Disposal of stake in Tictrac Limited

The Board of Puma VCT 13 plc is pleased to announce that Tictrac Limited ("Tictrac") has been acquired by Dialogue Health Technologies Inc. In 2020 the Company invested £1,850,000 in Tictrac. The exit represents a 1.93x return on the Company's investment, representing an IRR of 37.18%. The resulting cash proceeds attributable to the Company are not materially different from the value at which the Company currently holds its investment in Tictrac.

Tictrac offers an advanced health and wellness app for insurance companies and corporate clients to provide to their user bases. The app integrates data from wearable technology, delivering it to end users in a digestible format to drive up levels of engagement and increase customer loyalty.

For further information please contact:

Graham Shore

Puma VCT 13 plc

020 7408 4050

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DISUOOWRUKUVRRR

Talk to a Data Expert

Have a question? We'll get back to you promptly.